The program times are listed in Central European Time (CEST)

Displaying One Session

PARALLEL SESSION
Date
Wed, 02.06.2021
Session Type
PARALLEL SESSION
Session Time
20:10 - 21:40
Room
Hall C
PARALLEL SESSION

Introduction

PARALLEL SESSION

Pregnancy outcomes of 17,375 women with diabetes: National population-based cohort study

Abstract

Abstract Body

Background: Our aim was to compare risk factors associated with adverse pregnancy outcomes in women with type 1 and type 2 diabetes.

Methods: We included 17,375 pregnancies in 15,290 women with diabetes in a population-based cohort study across 172 maternity clinics. Obstetric complications (preterm delivery, large birthweight) and adverse pregnancy outcomes (congenital anomaly, stillbirth, neonatal death) were obtained for pregnancies during 2014-2018. We assessed associations between modifiable (glycaemia, obesity, clinic) and non-modifiable risk factors (age, deprivation, ethnicity) with pregnancy outcomes.

Results: Of 17,375 pregnancies, 8,690 (50.0%) were in women with type 1 and 8,685 (50.0%) in women with type 2 diabetes. The rates of preterm delivery (42.5% type 1, 23.4% type 2), and large birthweight (52.2% type 1, 26.2% type 2) were higher in type 1 diabetes (p<0.001). The prevalence of congenital anomaly (44.8/1000 type 1, 40.5/1000 type 2; p=0.175), and stillbirth (10.4/1000 type 1, 13.5/1000 type 2; p=0.072) did not differ but neonatal death rates (7.4/1000 type 1, 11.2/1000 type 2; p=0.013) were higher in type 2 diabetes. Independent risk factors for perinatal death were third trimester HbA1c > 48mmol/mol (OR 3.06, 95% CI 2.16 to 4.33), living in the highest deprivation quintile (OR 2.29 95% CI 1.16 to 4.52) and having type 2 diabetes (OR 1.65 95% CI 1.18 to 2.31). Variations in glycaemia and large birthweight were associated with maternal characteristics (diabetes duration, deprivation, BMI) without substantial differences between clinics.

Interpretation: No clinics were achieving appreciably better outcomes, suggesting that healthcare system changes are needed across all clinics.

Hide
PARALLEL SESSION

Factors associated with stillbirth in women with diabetes

PARALLEL SESSION

Week by week CGM profiles of pregnant women with type 1 diabetes

PARALLEL SESSION

DEBATE: Should all pregnant women with diabetes take metformin during pregnancy? - PRO

Date
Wed, 02.06.2021
Lecture Time
21:12 - 21:22
PARALLEL SESSION

DEBATE: Should all pregnant women with diabetes take metformin during pregnancy? - CON

Date
Wed, 02.06.2021
Lecture Time
21:22 - 21:32
PARALLEL SESSION

Live Q&A

Date
Wed, 02.06.2021
Lecture Time
21:32 - 21:40